Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Jacksonville, Florida

Phase 1 colorectal cancer trials in Jacksonville, FL

13 Phase 1 colorectal cancer studies are recruiting participants at sites in Jacksonville as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Jacksonville at a glance

  • 13 studies are recruiting at a site in Jacksonville.
  • By phase: Phase 1 (7), Phase 1/2 (6).
  • By sponsor: industry (13).
  • Most recent update to one of these records: November 3, 2026.

Studies recruiting in Jacksonville

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Mayo Clinic, Jacksonville
    Registry record
    NCT06720987 · updated
  2. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Mayo Clinic (Florida)
    Registry record
    NCT04657068 · updated
  3. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Mayo Clinic Comprehensive Cancer Center
    Registry record
    NCT06026410 · updated
  4. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT05919264 · updated
  5. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Exelixis Clinical Site #78
    Registry record
    NCT05176483 · updated
  6. A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05877599 · updated
  7. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Mayo Clinic Cancer Center
    Registry record
    NCT06445062 · updated
  8. A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cartography Biosciences
    Study site
    Mayo Clinic Florida
    Registry record
    NCT07321106 · updated
  9. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Xencor, Inc.
    Study site
    Xencor Investigative Site
    Registry record
    NCT05433142 · updated
  10. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

    • Phase 1
    • Ages 18 to 100
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT06562192 · updated
  11. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    858 Therapeutics, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT06395519 · updated
  12. A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    A2 Biotherapeutics Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT06682793 · updated
  13. A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GI Innovation, Inc.
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT05824975 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Ask about studies near Jacksonville

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call